Status Quo in Antibody-Drug Conjugates - Can Glyco- Enzymes Solve the Current Challenges?
Journal:
Protein & Peptide Letters
Volume:
24
Page:
686-695
Author(s):
Florentina Kubizek, Britta Eggenreich and Oliver Spadiut*
Bayes Syndrome and Imaging Techniques
Journal:
Current Cardiology Reviews
Volume:
13
Page:
263-273
Author(s):
Ivan Hernandez-Betancor, Maria Manuela Izquierdo-Gomez, Javier Garcia-Niebla, Ignacio Laynez-Cerdena, Martin Jesus Garcia-Gonzalez, A. Barragan-Acea, Jose Luis Irribarren- Sarria, Juan Jose Jimenez-Rivera and Juan Lacalzada-Almeida*
New Pharmacological Approaches to the Prevention of Myocardial Ischemia- Reperfusion Injury
Journal:
Current Drug Targets
Volume:
18
Page:
1689-1711
Author(s):
Kai Yee Chin, Chengxue Qin, Lauren May, Rebecca H. Ritchie and Owen L. Woodman*
Synthesis and Preliminary Cytotoxicity Studies of 1-[1-(4,5-Dihydrooxazol- 2-yl)-1H-indazol-3-yl]-3-phenylurea and 3-phenylthiourea Derivatives
Journal:
Medicinal Chemistry
Volume:
13
Page:
616-624
Author(s):
Anita Kornicka*, Franciszek Saczewski, Patrick J. Bednarski, Martyna Korcz, Piotr Szumlas, Ewa Romejko, Aneta Sakowicz, Lukasz Sitek and Monika Wojciechowska
Phosphoinositide-3-kinases as the Novel Therapeutic Targets for the Inflammatory Diseases: Current and Future Perspectives
Journal:
Current Drug Targets
Volume:
18
Page:
1622-1640
Author(s):
Preeti Vyas and Divya Vohora*
Renoprotection and Mechanisms of Erythropoietin and Its Derivatives Helix B Surface Peptide in Kidney Injuries
Journal:
Current Protein & Peptide Science
Volume:
18
Page:
1183-1190
Author(s):
Yufang Zhang, Weiwei Chen, Yuanyuan Wu and Bin Yang*
Immunomodulatory Role of Arsenic in Regulatory T Cells
Journal:
Endocrine, Metabolic & Immune Disorders - Drug Targets
Volume:
17
Page:
176-181
Author(s):
Rizwanul Haque*, Archana Chaudhary and Nadra Sadaf
Immunomodulatory Activity of MicroRNAs: Potential Implications for Multiple Myeloma Treatment
Journal:
Current Cancer Drug Targets
Volume:
17
Page:
819-838
Author(s):
Cirino Botta, Maria Cuce, Daniele Caracciolo, Lucia Fiorillo, Pierosandro Tagliaferri and Pierfrancesco Tassone*
Immunomodulatory Drugs (IMiDs) in Multiple Myeloma
Journal:
Current Cancer Drug Targets
Volume:
17
Page:
846-857
Author(s):
Shahzad Raza, Rachael A. Safyan and Suzanne Lentzsch*
Coinhibitory Molecule PD-1 as a Therapeutic Target in the Microenvironment of Multiple Myeloma
Journal:
Current Cancer Drug Targets
Volume:
17
Page:
839-845
Author(s):
Djordje Atanackovic, Tim Luetkens, Sabari Radhakrishnan and Nicolaus Kroger*